Compressive and Demyelinating Illness in the CNS (Neurology - Week 5) Flashcards

1
Q

True or False: Demyelination can occur in the peripheral or central nervous system

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Demyelination in the ____________ (peripheral/central) nervous system affects oligodendrocytes or their processes

A

central

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Demyelination in the ____________ (peripheral/central) nervous system affects Schwann cells

A

peripheral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the most common mechanism of injury to oligodendrocytes?

A

Damage to processes typically via an autoimmune mechanism (e.g., multiple sclerosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the most common mechanisms of injury for Schwann cells

A

1) genetic deficits (impair their ability to compact together or produce myelin sheath)

2) autoimmune mechanisms including self-reactive antibodies, antibody complexes or cytotoxic T cell damage to Schwann cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

_______________ is an immune-mediated disease directed against the CNS, which involves the loss of myelin (eventually leading to the loss of axons)

A

multiple sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some characteristic findings associated with multiple sclerosis?

A
  • chronic inflammatory findings
  • white matter lesions throughout brain and spinal cord
  • pathological specimens/(lesions?) are firm and hard in areas of white matter loss
  • highly variable (can affect anywhere in the CNS; can cause motor, sensory, cognitive, and mood-related signs/symptoms)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True or False: Multiple sclerosis (MS) is the most common demyelinating illness.

A

True

Note: MS has a prevalence of about 1/1000 in North America and Europe, is 3x more likely in women, and tends to begin in young adulthood/middle age (peak incidence between 20 and 40)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

About how many people in Canada are affected by MS?

A

100, 000 (now)
130, 000 (estimated by 2031)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MS is polygenetic. What does this mean?

A

Polygenetic = multiple genes are involved/affected

For MS in particular, they are HLA-II genes (DRB1/DRB15; gene most associated with the disease) and the genes for IL-2, IL-7, and IL-17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the risk of developing MS if a first-degree (e.g., mother, father, sibling) relative is diagnosed?

A

15x higher risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the risk of developing MS if your monozygotic twin is diagnosed?

A

150x higher risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If it’s not genetic, what else could cause MS?

A
  • viral infections (e.g., EBV)
  • limited sun exposure and low vitamin D
  • history of other autoimmune disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Does MS have an acute inflammation phase before chronic inflammation?

A

No – goes straight to chronic inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the two phases of MS pathogenesis?

A

1) First Phase = Active Plaques: presence of typical leukocytes found during chronic inflammation –> destruction of myelin/oligodendrocytes

2) Second Phase = Inactive Plaques: loss of axons (and eventually neurons) with limited to no leukocytic infiltration and prominent gliosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the major leukocytes involved in the first phase of MS pathogenesis?

A
  • CD4+ Th cells (primarily Th1 and Th17)
  • cytotoxic T cells
  • B cells
  • macrophages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Where do MS plaques form?

A

Typically adjacent to…
- lateral ventricles
- optic tracts
- brainstem
- cerebellum
- and spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

True or False: cerebral atrophy may result over time in an individual with MS

A

True

Note: loss of neurons = loss of brain tissue therefore shrinks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

True or False: leukocytes are recruited and cross the blood-brain-barrier (BBB) during the active phase of MS

A

True

Note: there should be very few to no leukocytes in a normal CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Helper T cells initiate an immune response against __________________ during the active phase of MS

A

myelin basic protein (MBP)

note: MBP helps to compact the layers of myelin sheath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Leukocytes that have crossed the BBB in the active phase of MS, then recruit other leukocytes (e.g., cytotoxic T cells and macrophages) into ____________ and activate them

A

white matter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which leukocyte attacks the oligodendrocytes in MS?

A

cytotoxic T cells

Recap: the helper T cells (and B cells) are attacking the myelin itself, while the cytotoxic T cells are attacking the oligodendrocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Other than helper T cells, what other leukocyte can destroy the myelin sheath in the active phase of MS?

A

MBP-specific B-lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is a period of worsened neurological symptoms (in MS)?

A

flare

Note: in between flares, there are fewer chronic inflammatory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Areas where lymphocytes reside “permanently” as flares continue are called what?

A

lymphocytic follicles

Note: these are prominent around the meninges and blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Inactive plaques are plaques without prominent _____________

A

inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What happens to axons as they lose their “blanket”?

A
  • degeneration
  • fewer action potentials
  • and eventually neuronal cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How do axons compensate for demyelination?

A

Redistribution of sodium channels to aid action potential conduction

Note: since we don’t have anymore myelin, the signal is not travelling as fast, so we need a way to speed things up/help the axon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the most common initial symptoms of MS?

A
  • paresthesias (tingling/numbness) in one or more extremities, the trunk, or one side of the face
  • weakness or clumsiness of a leg or hand
  • visual disturbances (e.g., partial loss of vision, optic neuritis pain, diplopia, scotomas, nystagmus, dizziness)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the most common initial symptom of MS?

A

sensory loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is/are the most common cognitive sign/symptom(s) of MS?

A

fatigue and depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is L’hermitte’s phenomenon?

A

L’hermitte’s phenomenon = sensation of an electrical shock running down the back and along the limbs

Note: it is one of the signs/symptoms of MS but is NOT sensitive or specific for MS

33
Q

True of False: Pain is present in about 50% of MS patients

A

True

34
Q

What are some motor symptoms of MS?

A
  • bilateral spastic weakness (mostly in lower extremities)
  • increased deep tendon reflexes (3+ or 4+)
  • charcot triad: dysarthria, nystagmus, tremor
  • facial twitching (myokymia)
  • slurred speech
35
Q

What are some brainstem and spinal cord findings of MS?

A
  • dizziness
  • bladder dysfunction
  • constipation
  • erectile dysfunction (men) or genital anesthesia (women)
  • frank urinary and fecal incontinence (advanced cases)
35
Q

What are some sensory signs/symptoms of MS?

A
  • paresthesia (abnormal sensations on skin, e.g., numbness, tingling, burning)
  • pain (in 50% of cases)
  • L’hermitte’s phenomenon (electrical “shock”)
35
Q

True or False: Other signs/symptoms of MS include heat and activity intolerance.

A

True

Note: hotter environments = APs going faster and if we don’t have myelin, it’s going to take more ATP

35
Q

What is Uhthoff sign?

A

when a hot environment/shower/physical exertion leads to blurry vision, due to a transient worsening of neurological function in response to increases in core body temp

35
Q

How do you diagnose MS?

A

1) a symptom and history checklist (known as MacDonald’s criteria)

Aided by…

2) characteristic lesions on brain and spinal cord (via MRI)

3) presence of certain antibodies in CSF (via spinal tap)

36
Q

Describe the simplified MacDonald criteria

A

Requires:
- documentation of two or more episodes of symptoms + two or more signs
- pathology in anatomically noncontiguous white matter tracts of CNS
- symptoms last for more than 24h
- must occur as distinct episodes that are separated by a month or more
- MRI can take place of second occurrence of 2 signs/2 symptoms

36
Q

Is there a cure for MS?

A

No

36
Q

What is the prognosis for MS?

A
  • relapsing-remitting = most common (90% of patients first presenting with MS)
  • secondary progressive (1% of patients with MS develop this type each year)
  • primary progressive (10% of patients first presenting with MS)
36
Q

How do we treat MS?

A
  • immunomodulators for chronic treatment (e.g., Natalizumab, copaxone, interferon-like drugs)
  • steroids for acute flares
36
Q

Is the prognosis better or worse for relapsing-remitting MS vs. primary progressive MS?

A

primary progressive is worse compared to relapsing-remitting

37
Q

True or False: secondary progressive MS is often more responsive to immunomodulatory drugs

A

False.

Secondary progressive MS is less responsive to immunomodulatory drugs.

38
Q

Mortality is _________ (common/uncommon) in MS, and significant functional disability is __________ (normal/not normal).

A

uncommon, normal (30-50% even with therapies)

39
Q

The functional disturbance and/or pathological change in the PNS is known as

A

neuropathy

40
Q

Pain in the distribution of a particular nerve, usually in the absence of objective signs is known as

A

neuralgia

41
Q

Inflammation of a nerve is called

A

neuritis

42
Q

Pain along a dermatome (implying that the problem is at the level of the nerve root) is known as

A

radiculopathy

43
Q

Neuropathy of the entire plexus is called

A

plexopathy

44
Q

True or False: Neuropathies can be sensory, motor, autonomic, or a combination

A

True

45
Q

How does polyneuropathy present?

A
  • symmetrical distal weakness
  • symmetrical distal sensory loss (stocking and glove)
  • hyporeflexia
46
Q

How does multiple mononeuropathy present?

A
  • involves more than 1 nerve, but NOT in a symmetrical fashion

Note: often due to toxins, diabetes, AIDS, chronic inflammatory disease (e.g., RA, SLE)

47
Q

Charcot-Marie-Tooth (CMT) Disease is also known as

A

hereditary motor and sensory neuropathy (HMSN)

48
Q

True or False: Charcot-Marie-Tooth Disease is the most common inherited neurologic disorder

A

True

prevalence = 1/2500

49
Q

True or False: Charcot-Marie Tooth Disease has an autosomal dominant inheritance pattern with variable penetrance (not the same severity in everyone)

A

True

50
Q

CMT1/HMSN1 pathophysiology

A

demyelination of peripheral nerves due to abnormal myelin production, damage to nerves, and thickened palpable myelin sheaths

Note: the proteins involved in myelin compaction are defective, leading to demyelination/remyelination cycles

51
Q

CMT2/HMSN2 pathophysiology

A

axonal death and degeneration without a primary defect in myelin (aka your myelin is fine but for some reason axons are still dying)

Note: less common

52
Q

How does Charcot-Marie-Tooth Disease present clinically?

A
  • both sensory and motor symptoms
  • slowly progressive distal symmetrical muscle weakness and atrophy (champagne bottle legs)
  • diminished DTRs, foot drop, pes cavus (high arches even with weight) with hammer toes
  • proprioception and touch affected (less pain and temperature sensation)
  • nerves can become enlarged and palpable with cycles of myelination and remyelination
53
Q

How do you diagnose CMT?

A
  • nerve biopsy and nerve conduction studies
  • physical exam
  • history
54
Q

How do you treat CMT?

A
  • massage, ROM to prevent contractures
  • anti-inflammatories
  • analgesics
55
Q

What is the prognosis for CMT?

A
  • most have normal life expectancy
  • involvement of phrenic nerve (diaphragm) or cranial nerves is very rare
  • usually exclusively affects the lower leg
56
Q

Acute onset immune-mediated demyelinating neuropathy is known as

A

Guillain-Barre Syndrome (GBS)

Note: it is an uncommon disease

57
Q

Although it is an uncommon disease, what is the most common cause of Guillain-Barre Syndrome (GSB)?

A

acute flaccid paralysis

1.5/100, 000 per year

58
Q

What is the pathogenesis of GBS?

A
  • usually occurs after infection (2/3 with flu-like symptoms)
  • usually related to infections of Campylobacter jejuni, cytomegalovirus, Epstein-Barr virus, and Mycoplasma pneumoniae, OR prior vaccinations
  • T-lymphocytes that presumably recognize myelin cause segmental demyelination
  • macrophages and antibodies also involved in nerve damage
  • nerve conduction is slowed and may be blocked completely
  • after 2-3 weeks of demyelination, the Schwann cells begin to proliferate, inflammation subsides, and re-myelination begins
59
Q

How does GBS present clinically?

A
  • acute, rapid, progressive inflammatory polyradiculopathy
  • involves mostly MOTOR symptoms
  • ascending symptoms (weakness starts in lower limbs, then progresses to higher regions of the body)
  • sphincters tend to be spared

Note: flaccid paralysis can be life-threatening if it progresses to involve the phrenic nerve (C3, C4, C5)

60
Q

How do you diagnose GBS?

A
  • history and physical
  • EMG and nerve conduction studies are also helpful
61
Q

How do you treat GBS?

A
  • protect airway, ventilation
  • plasmapheresis (removal of antibodies from the blood)
  • IV immunoglobulins
62
Q

What is the prognosis of GBS?

A

If the patient survives the initial disease, the prognosis is good. However, some have prolonged functional deficits for 2 years or more.

If not recognized and treated = very high mortality

63
Q

What does compression of a nerve in the PNS lead to?

A
  • pain (very common)
  • reduction or loss of function (motor - weakness or flaccid paralysis; sensory - numbness/anaesthesia/tingling, pins-and-needles/dysaesthesia)
64
Q

Pathological theories of compressive nerve damage include… ?

A

1) Direct mechanical damage to the nerve (crush injury); death of the nerve likely only in severe cases

2) Ischemia (compression of the blood vessels in the perineurium = decreased blood flow and reduced function in the nerve); again, nerve usually survives unless very severe…. this is the more important mechanism

65
Q

Idiopathic paralysis of the facial nerve is known as what?

A

Bell’s Palsy

note: the most common cause of unilateral facial paralysis (23/100, 000 per year)

66
Q

True or False: Bell’s Palsy tends to occur in children

A

False.

Tends to occur in adults

67
Q

Bell’s Palsy is thought to be compression of the facial nerve caused by edema/inflammation cause by ____________

A

herpes virus

Note: normally lies dormant in the cell body of neurons, but can reactivate and lead to edema of the facial nerve (CN7)

68
Q

What are some of the clinical features of Bell’s Palsy?

A
  • acute onset of unilateral upper and lower facial paralysis (over 48 hour period)
  • posterior auricular pain
  • earache
  • decreased tearing or epiphora (excess tears)
  • hyperacusis (reduced tolerance to sound)
  • taste disturbances
  • otalgia (ear pain)
  • poor eyelid closure
69
Q

How do you diagnose Bell’s Palsy?

A

Mainly clinical (signs and symptoms)

70
Q

How do you treat Bell’s Palsy?

A

Steroids and antivirals have limited value

Surgery in stubborn cases

71
Q

What is the prognosis for Bell’s Palsy?

A

Tends to resolve on it’s own over time (more than 80% of cases)